|
Real-time Estimate
Cboe BZX
16:52:06 30/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 42.56 USD | +1.72% |
|
+2.13% | -16.37% |
| 10-30 | Supernus Pharmaceuticals, Inc., Q3 2026 Earnings Call, Oct 29, 2026 | |
| 10-30 | Earnings Flash (SUPN) Supernus Pharmaceuticals Posts Q3 EPS $0.35, vs. FactSet Est of $0.08 Loss | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Specialty & Advanced Pharmaceuticals | -0.66% | +2.13% | -16.37% | -26.43% | +37.00% | 2.43B |  |  | |
- Stock Market
- Stocks
- SUPN Stock
- Charts Supernus Pharmaceuticals, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
